 The purpose of this clinical trial is to compare a non-pharmaceutical intervention Integral Attention Program or PAI versus standard palliative chemotherapy treatment plus PAI in patients with advanced cancer who have already received at least a first course of chemotherapy but had proven therapeutic failure. 